Exenatide Exendin-4 is a hormone extracted from the venom of the lizard Heloderma suspectum, exhibiting biological effects similar to human GLP-1
Berberine slips into intestinal cells and coaxes them to release a little more of the peptide
175 REMOVAL (Reducing with Metformin Vascular Adverse Lesions) trial which is one of the longest and largest trials of metformin treatment within type 1 diabetes patients reported a small but sustained reduction in LDL cholesterol and weight in middle-aged adults over 3 years
The care model is intentionally streamlined: onboarding takes minutes, prescriptions are processed quickly, auto-refills are built in, and dose adjustments follow a simple escalation pathway
Secondary 2026 commentary estimates possible MHRA approval in late 2027 or 2028 [1][2] [unverified, not a Lilly primary statement]
PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) evaluates predispositions in GLP-1 receptor signaling, glucose-dependent insulinotropic peptide (GIPR) function, and metabolic genes like FTO and MC4R
